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Two cell-bound serine esterases are required for the chemotactic response of 
rabbit  peritoneal  polymorphonuclear leukocytes to  C'(5,6,7)a,  the  comple- 
ment-dependent chemotactic factor of high molecular weight  (1).  This has 
been demonstrated primarily through the use of several homologous series of 
p-nitrophenyl ethyl phosphonate esters of the following general structure: 
~)/OC,I-I. 
R--P\ 
O~NO2 
These compounds are specific, irreversible inhibitors of serine esterases. Their 
inhibitory activity varies in the different homologous series  with changes in 
structure of the R group to give the so called "inhibition profiles." These inhibi- 
tion profiles are characteristic for and specific to such well-defined esterases as 
trypsin, chyinotrypsin, acetylcholinesterase, and  Crla  (2,  3),  as well as  the 
esterases involved in the antigen-induced release of histamine from sensitized 
slices of guinea pig lung and from rat peritoneal mast cells sensitized with rat 
homocytotropic antibody or with rabbit anti-rat gamma globulin (reviewed in 
reference 4). 
The "activated esterase," one of the two serine esterases involved in chemo- 
taxis, exists in or on the leukocyte in an already activated state fully susceptible 
to the inhibitory action of the phosphonates; it has a special affinity  for acetate 
esters (5). The other, or activatable esterase, the subject of this paper, is an 
esterase of the polymorphonuclear leukocyte existing in a  form which is en- 
* This work was partially supported by the National Institutes of Health, Bethesda, Md., 
Grant No. AI-07291-AIA. 
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zymatically inert and thus insusceptible to the inhibitory activity of the phos- 
phonates. On contact of the leukocyte with Ct(5,6, 7)a, the serine esterase be- 
comes activated and thereby susceptible to inhibition by the phosphonate. 
A concentration gradient of the chemotacfic factor must be present for the 
leukocyte to  respond  chemotactically. When  the  polymorphonuclear leuko- 
cytes are incubated in a solution containing the chemotacfic factor, chemotaxis 
cannot occur since there exists no gradient of the factor. Nevertheless, the cells 
have interacted with the chemotactic factor as shown by the progressive loss of 
their ability to respond chemotacfically to  C1(5,6,7)a when  they are  tested 
under the proper conditions. This progressive loss of responsiveness under the 
influence of the chemotactic factor is termed "deactivation" (6). 
Deactivation can be prevented by the phosphonates in a manner indicating 
that the activatable esterase is involved. Deactivation is also specifically pre- 
vented by aromatic amino acid derivatives; nonaromatic amino acid deriva- 
tives have no effect. The aromatic amino acid derivatives also directly inhibit 
chemotaxis. These latter findings, together with the demonstrated involvement 
of the activatable esterase in both deactivation and chemotaxis, suggested the 
hypothesis  that  the  activatable  esterase  of  the  rabbit  polymorphonuclear 
leukocyte is  a  serine  esterase with  special  affinity for  aromatic  amino  acid 
derivatives, that is, the activatable esterase is an aromatic amino acid esterase 
(5). 
In order to prove this hypothesis it is necessary to show that: 
1.  An esterase capable of hydrolyzing aromatic amino acid esters is present 
in or on the rabbit leukocyte. 
2.  The aromatic amino acid esterase is inactivated by phosphonate esters in 
a manner characteristic of the inhibition of serine esterases, that is, the inhibi- 
tion is irreversible and follows the expected kinetic course. 
3.  The inhibition profiles of the aromatic amino acid esterase obtained with 
the several homologous series of phosphonate esters are the same as those found 
for the activatable esterase in both chemotactic factor-dependent inhibition of 
chemotaxis and protection against deactivation. 
4.  The  aromatic  amino  acid  esterase  exists  in  a  precursor form which  is 
insusceptible to phosphonates until it is activated. 
5.  The precursor form of the aromatic amino acid esterase is capable of being 
activated by interaction of the cell with the chemotacfic factor. 
This paper ~11 demonstrate that the first three of the above criteria have 
been fulfilled. The rabbit  peritoneal polymorphonuclear leukocyte has  three 
esterases  capable  of  hydrolyzing the  aromatic  amino  acid  ester,  acetyl DL- 
phenylalanine ~-naphthyl ester; two of the three esterases are inhibitable by 
phosphonates in a manner characteristic of serine esterases, and one of the two 
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Materials and Methods  1 
Leukocytes.--Glycogen was used to induce in rabbits a peritoneal exudate of which 95% or 
more of the cells consisted of neutrophilic polyrnorphonuclear leukoeytes. The methods of in- 
ducing the exudate and collecting and washing the leukocytes were as previously described 
(1). When the terms "leukocyte"  or "cell" are used, the rabbit peritoneal polymorphonuclear 
leukocyte is meant unless otherwise indicated. 
Buffer.--The  buffer (TGS) used throughout the present studies was prepared by making a 
1:25 dilution of 0.5 ,~ tris (hydroxymethyl) amino methane (Tris) pit 7.4, and a 1:100 dilution 
of 10% gelatin with 0.15 ~  NaC1. 
Pkospkonates.--The phosphonates were of the general structure pictured above; they have 
all been described previously (2, 3). R  was either a phenylalkyl, alkyl, or chloroalkyl group 
with varying numbers of carbon atoms in the alkyl chain. In what follows,  the phosphonates 
are named according to the nature of R, the presence of the p-nltrophenyl and ethoxy groups 
being implied. 
Acetyt ~L-Pkenylalanine {3-naphthyl Ester.--The substrate was obtained from Mann Research 
Laboratories, N. Y. For use,  16 mg was dissolved in 6 ml of  reagent  grade N,N-dimethyl 
formamide and 12 ml acetone (Fisher Scientific Co., Silver Spring, Md.). Immediately before 
the cells were to be assayed, one volume of the substrate solution was added to nine volumes of 
TGS. 
Coupling  Reagent.--ll.5  mg of  Fast Scarlet  salt  GGN  (General  Dyestuff  Co.,  Chicago,  Ill.) 
and 115 mg of  Duponol ME  Dry (E.I.  du Pont de  Nemours & Co.,  Wilmington, Dcl.)  were 
freshly  dissolved  in  7.5  ml  of  distilled  water  for  each  experiment. 
Estera~e  Assay.--The esterasc  assay  was modified  from the one Cohen and Erianger de- 
scribed  for  chymotrypsin (7).  In  this  assay,  the  naphthol  set  free  by  the  action  of  the  esterase 
on  the  substrate  is  measured  by  the  intensity  of  the  orange  red  color  it  forms  when  conjugated 
with  the  Fast Scarlet  diazonium salt. 
In  duplicate,  2  ml  of  the  acetyl  m.-phenylalanine  ~-naphthyl  ester  solution  in  TGS was  added 
to  0.5  ml  of  a  suspension  of  leukocytes  also  in  TGS. The  suspension  usually  contained  between 
1-2.5  X  10  7  polymorphonuclear leukocytes.  The cell-substrate  suspension  was incubated at 
37°C in a  shaking water bath. At 0, 5,  10, and 15 rain, or occasionally at shorter intervals, 
0.5 ml aliquots were removed, mixed with 0.15 ml of the coupling reagent, and allowed to stand 
10 rain at room temperature for maximum color development. 1 ml of acetone was then added 
and thoroughly mixed, and the cells and precipitated protein removed by centrifugation. The 
clear supernatant was read at 485 m# in a  modal 300 Gilford spectrophotometer against a 
blank. The blank was 0.5 ml of TGS to which 2.0 ml of substrate had been added and treated 
as above. 
The presence of an excess number of leukocytes interfered with the color development as 
determined by the addition of ~-naphthol to cells. This created difficulty in the esterase assay 
as seen in Fig. i. This figure shows the results obtained from two experiments where varying 
leukocyte concentrations were assayed. It is evident that only at the lower cell concentrations 
was the increase in the liberated ~-naphthol linear with time, or more importantly, at any 
given time, was the activity a linear function of cell concentration. Calculation showed that 
exhaustion of the substrate was not the reason for the lack of linearity. 
Before every experiment it was therefore necessary to test varying concentrations of leuko- 
1 The "Principles of Laboratory Animal Care" as promulgated by the National Society for 
Medical Research were observed during this study. Animal facilities were provided by the 
Animal Care Branch of the Armed Forces Institute of Pathology. ~L 
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FIO. 1. The results of two experiments on the effect of the concentration of rabbit peritoneal 
polymorphonuclear cells on the relation between the time of incubation of the cells and their 
activity in hydrolyzing acetyl DL-phenylalanine  ~-naphthyl ester (upper curves), and the ef- 
fect of the time of incubation on the relation between the concentration of rabbit peritoneal 
polymorphonuclear  leukocytes  and  their  activity in  hydrolyzing  acetyl  DL-phenylalanine 
~-naphthyl  ester  (lower curves).  Experiment  1,  A-.-A;  experiment 2  G  Q;  all cells 
incubated at 37°C and pH 7.4. 
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cytes in  order to determine the  range of  concentrations in  which the  activity  was a linear  func- 
tion of the number of cells.  On the basis  of this  preliminary determination, the concentration 
of cells  was chosen which, after 10 rain  incubation, gave maxlmum  activity  that was on or 
nearly on  the  linear  portion of  the  curve relating  cell  concentration to activity. 
Other experiments demonstrated that the total esterase activity was a function of tempera- 
ture and concentration of substrate as expected for an enzymatic reaction. These experiments 
are not shown here, since the existence on the leukocyte of three esterases capable of hydrolyz- 
ing acetyl vL-phenylalanine ~-naphthyl ester (see below) robs the results of any quantitative 
significance. The concentration of substrate used in the final assay was far from a saturating 
one; unfortunately, it could not be increased due to the insolubility of the ester. Increasing 
the concentration of organic solvent to increase the solubility of the substrate decreased the 
activity of the enzyme. The optimum activity was between pH 7.3 and 7.7  and decreased 
distinctly on either side of this range. 
Pkosphona~ I,h~io,.---O.1 ml of the appropriate dilution in acetone of the phosphonate 
ester was added by micropipette to 1.9 ml of the leukocyte suspension in TGS. As a control, 
0.1 nfl of acetone was added to another 1.9 ml sample of cells. After thorough mixing, the cells 
and inhibitors were allowed to stand for 15 rain at room temperature (27°C). At the end of this 
time, 6 ml of ice-cold TGS was added and the cells immediately centrifuged in the cold for 5 
min at 150 g. After this centrifugatiou, the cells were washed twice with 8 ml of ice-cold TGS, 
mM~i,g sure the tubes were thoroughly drained after each wash. The cells were then suspended 
to a final volume of 0.5 ml with TGS and assayed. 
The final concentrations of cells used were between 0.8 and 3 X  10~/2.5  ml. In any given 
experiment, the concentration was chosen on the basis of a preliminary determination so as to 
be on the linear portion of the curve relating activity to cell concentration (see above). Be- 
cause the cells varied somewhat from one experiment to  another in esterase activity and 
degree of inhibition by phosphonate, comparisons were made only in experiments performed 
on the same batch of cells at the same time. 
The use of low concentrations of  phosphonate  (1 X  10-s-1 X  10  ~  x~) frequently led  to 
highly erratic results if the preliminary dilutions were made in buffer. This was presumably 
due to the adsorption of the inhibitor to glass. All preliminary dilutions of the phosphonates 
were therefore made in acetone rather than buffer before adding to the cell suspension. 
RESULTS 
Demonstration  of  Two  Esterases  with  Widely  Varying  Susceptibility  to  the 
Inhibitory Action of the Phosphonate  Esters.--The  reaction of an organophos- 
phorus inhibitor, such as one of the phosphonate esters, with a serine esterase 
is bimolecular and irreversible in nature. As a consequence, when varying con- 
centrations of the inhibitor (all in high excess relative to the enzyme) are reacted 
with the esterase for a fixed time, the logarithm of the activity plotted against 
the concentration of inhibitor gives a straight line. However, this did not result 
when  phenylphosphonate  (Fig.  2),  5-chloropentylphosphonate  (Fig.  3),  or 
other phosphonates  were used  to  inhibit  the  esterase  activity  of  the  rabbit 
peritoneal leukocytes. 
In these experiments, the leukocytes were incubated with varying concentra- 
tions of phosphonate esters for a constant time of 15 rnln and then assayed for 
residual acetyl DL-phenylalanine/3-naphthyl esterase activity. As seen in Fig. 2, 
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progressively decreased the activity of the enzyme and, as expected, the loga- 
rithm of the residual activity plotted against the concentration fell on a straight 
line  which  extrapolated  at  zero inhibitor  concentration  to  the  total  activity 
given by the control not exposed to inhibitor. An additional 10-fold increase in 
concentration  to  10  -7 z~ phenylphosphonate  led  to only a  slight  further  de- 
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F~G. 2. The acetyl DL-phenylalanine  fl-naphthyl  esterase activity rem~ining after contact 
of rabbit peritoneal polymorphonucleax leukocytes for 15 rain at 27°C with varying concentra- 
tions of p-nitrophenyl ethyl phenylphosphonate. Note that the concentration scale of the upper 
curve is from 0 to 1 ×  10  -s M phosphonate,  whereas that of the lower curve is from 0 to 
1 ×  10  -4 xt phosphonate. 
crease in esterase activity. However, a further progressive decrease in residual 
enzyme activity occurred on increasing  the  concentration  of inhibitor  above 
10  -7 ~. Plotting the logarithm of the residual  esterase activity over the range 
of concentration of 10-L10  q  ~  phenylphosphonate (bottom scale, Fig. 2) also 
gave a straight line, but the apparent activity extrapolated to zero concentra- 
tion of inhibitor was the same as the activity found at 1.0 X  10  -7 ~  phenyl- 
phosphonate. Repetition of the entire experiment on another day with another 
batch of cells and the inhibitor gave essentially the same results. X 
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When  the same experiment was repeated with  5-chloropentylphosphonate, 
the results were the same as those found with the phenylphosphonate except 
for quantitative  differences  (Fig.  3).  Increasing  the  concentration  of  the  5- 
chloropentylphosphonate from 2  X  10-9-6  X  10  -9 ~  yielded  a  progressive, 
irreversible inhibition of enzyme activity; the linear relation over this range of 
inhibitor concentrations was of the same nature as that seen with the phenyl- 
phosphonate. Increasing the concentration of inhibitor from 6 X  10-9-1 X  10  -s 
M, 3  X  10  -s ~, 6 ×  10  -s ~, or 1 ×  10  -7 M led to no further decrease in esterase 
activity. Increasing the phosphonate concentration over the range of 6 X  10-  7- 
6 X  10  -s ~  resulted in a further progressive, irreversible fall in esterase activity; 
the logarithm of the residual esterase activity plotted against this range of in- 
hibitor concentrations gave a  straight line which  extrapolated to the enzyme 
TABLE  I 
The Existence of Three Esterases Capable of Hydrolyzing Acetyl ~L-Phenylalanine 13-Naphthyl 
Ester  as  Shown  by  Their  Differential  Susceptibility  to  p-Nitrophenyl  Ethyl 
5-Chloropentylphosphonate 
Inhibitor concentration, ,~*  Esterase activity, OD~ 
0  1.035 
1 X  10  -~  0.30 
4  X  10  ~  0.15 
* 4  X  l0 T rabbit  peritoneal  polymorphonuclear leukocytes  were  incubated  with  the 
above concentrations of inhibitor for 15 min at 27°C in a volume of 2 ml. At the end of that 
time, the cells were washed and assayed as described in materials and methods. 
:~ Optical density (OD) at 485 m#. 
activity remaining after treatment of the cells with concentrations of 5-chloro- 
pentylphosphonate ranging from 6 X  10-°-1  >(  10  -~ •.  When this experiment 
was  repeated,  essentially  the  same results  were  obtained;  butylphosphonate 
gave inhibition curves (not shown here) which were of the same nature as those 
in Figs. 2 and 3. 
These results indicate that the rabbit peritoneal polymorphonuclear leuko- 
cyte  contains  two  esterases  capable  of hydrolyzing  acetyl  Dl.-phenylalanine 
fl-naphthyl ester and that they have a 10,000-fold or greater difference in their 
sensitivity  to  irreversible  inhibition  by  phosphonate  esters.  The  most  sus- 
ceptible enzyme we termed esterase 1, and the less susceptible, esterase 2. 
Demonstration  of  the  Existence  of  a  Third  Esterase  Insusceptible  to  Phos- 
phonate Action.--In  addition to esterases 1 and 2,  there is evidence for a  third 
esterase,  esterase  3,  which  is  also  capable  of  hydrolyzing  acetyl  DL-phenyl- 
alanine/5-naphthyl ester; in contrast to esterases 1 and 2, it is not inactivated 
by the highest obtainable concentration of any of the phosphonates. The re- 
suits  of an  experiment demonstrating  the  existence  of this  last  activity are EL~ER  L. BECKER  AND  PETER A. WARD  577 
depicted in Table I. In this experiment, advantage was taken of the fact that 
1  X  10  -7 ~r chloropentylphosphonate should inactivate all of esterase 1, but 
leave intact the activity attributable to esterase 2. Similarly, incubation with 
4  X  10--* ~r chloropentylphosphonate for the indicated time should leave less 
than 1% of the activity of esterase 2 (see Fig. 3). In the experiment of Table I, 
duplicate samples of leukocytes were incubated for 15 min with 1 X  10  -7 and 
4 X  10  -4 M chloropentylphosphonate or with acetone, washed, and the esterase 
activity determined as described. The total activity was  1.04 optical density 
units; this was reduced to 0.30 units by treatment with 1 X  10  -7 ~t inhibitor, 
bat reaction of the enzyme with 4  X  10  -4 ~t 5-chloropentylphosphonate still 
left 0.15 units of activity. This last activity which was resistant to high concen- 
trations of phosphonates was attributed to esterase 3. The results of Table I 
indicate that the samples of leukocytes had 70 % of its activity due to esterase 
1, 15 % owing to esterase 2, and 15 % attributable to esterase 3. 
Similar results were obtained when leukocytes were treated with other phos- 
phonates in the same fashion or when the incubation period was increased be- 
yond 15 mln. Wide variations were found in the proportions of total enzyme 
activity ascribable to the three esterases from one batch of cells to another. We 
have no explanation for these fluctuations, but suspect they are associated with 
variations in the functional capacities of the cell. 
Inhibition Profiles of Esterases I and 2.--The relationship between the length 
of the alkyl chain and the potency of the phosphonates in reducing the activity 
of esterase 1 and esterase 2 was determined for the phenylalkylphosphonates, 
the chloroalkylphosphonates, and  the  alkylphosphonates.  In  a  given experi- 
ment with one of the homologous series of phosphonates, a single batch of cells 
was used to ascertain the inhibition profiles of one or another of the two ester- 
ases. In every case, the results were confirmed by repetition of the experiment 
using  another  batch  of  cells  and  independently  prepared  dilutions  of  the 
phosphonates. 
In determining the inhibition profiles of esterase 1, the leukocytes were in- 
cubated, as described in Materials and Methods, with each of the phosphonates 
at a single, constant concentration between 2 X  10  -9 and 8 X  10  -9 ~. In deter- 
mining the inhibition profiles of esterase 2,  the cells were incubated with the 
same  inhibitors  at  a  single,  constant  concentration  between  5  X  10  -e  and 
5  X  10  -4 1~. The exact concentration used in the two cases depended on the 
homologous series of phosphonates being tested and the particular experiment. 
In each experiment, cells were also incubated with 5 %  acetone to give the 
total control activity, and other cell samples were incubated with a concentra- 
tion  of phosphonate  which  would  completely inactivate esterase  1,  but  not 
affect esterase 2. Phenylphosphonate, 5-chloropentylphosphonate, and butyl- 
phosphonate,  at 1  >(  10  -7 ~r final concentrations, were used for this purpose 
(see Figs. 2 and 3), when their respective homologous series were tested. 
The total  activity of esterase  1  was  taken  as  the  difference between  the 578  ESTERASES  O~  POLYMORPHONUCLEAR  LEUKOCYTES 
activity of the uninhibited control and the activity found after treatment of 
the cells with 1 X  10  -7 ~r phosphonate. The per cent inhibition of esterase 1 by 
a given phosphonate was obtained by subtracting the activity remaining after 
treatment of the cells at a concentration of the phosphonate which would not 
give 100 % inactivation of esterase 1 from the total activity found for esterase 
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FIG. 4. The comparison of the inhibition profiles of esterase  I  0.-I----I-:I)  and esterase 
2((3  (3) obtained when the rabbit peritoneal polymorphonuclear  leukocyte  is reacted with 
the phenylalkylphosphonates,  the chloroalkylphosphonates,  or the alkylphosphonates. 
1, dividing this difference by the total esterase 1 activity and multiplying this 
ratio by 100. 
The activity remaining after  treatment of the cells with  1 X  10  -7 ~  phos- 
phonate was ascribed to esterase 2. The small amount of activity attributable to 
esterase 3 was ignored since it became evident that the minor contribution of 
this activity would not alter the shape of the inhibition profiles of this esterase. 
The per cent inhibition of esterase 2 by a  given phosphouate was determined 
by subtracting the activity obtained after treatment of the cells with a concen- 
tration of phosphonate which would not completely inhibit esterase 2 from the ELMER L.  BECKER AND PETER A.  WARD  579 
total activity due to esterase 2, dividing this by the total activity due to esterase 
2 and multiplying the ratio by 100. 
The  inhibition  profiles given  by  the  phenylalkyl,  chloroalkyl,  and  alkyl- 
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FIG. 5. A stmcture~activity comparison of the ability of chloroalkylphosphonates, alkyl- 
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deactivation ($  $), and give chemotactic factor dependent inhibition ((D ..... Q). The 
curves for protection against deactivation and chemotactic factor dependent inhibition were 
taken from reference 6. 
phosphonates acting on esterases 1 and 2 are depicted in Fig. 4. It is evident that 
the inhibition profiles of the two esterases differ for each of the three series of 
phosphonates. When the phenylalkylphosphonates are reacted with esterase 1, 
the phenylethylphosphonate shows a  distinct  minimum in activity, whereas, 
with esterase 2, the minimum is at the benzylphosphonate and the phenylethyl- 580  ESTEKASES  OF  POLYMORPHONUCLEAI~  LEUKOCYTES 
phosphonate  is  optimally active.  In  the  chloroalkylphosphonate series,  the 
chlorobutylphosphonate exhibits maximal,  and  the chloropentylphosphonate 
minimal, activity against esterase 1, whereas there is a progressive increase of 
activity against esterase 2 as the number of carbon atoms is increased in the 
alkyl chain of the chloroalkylphosphonates. With both esterase 1 and 2,  the 
results with the alkylphosphonates are almost the same as with the chloroalkyl- 
phosphonates. 
In each instance, the inhibition profiles were reproducible, independent of the 
number of cells used or whether the inhibition was run at 4 ° or 27°C, and were 
not affected by experimentally feasible variations in the concentration of in- 
hibitor. The differences in their inhibition profiles indicate that the two ester- 
ases can be distinguished by this means as well as by the very great differences 
in the concentrations of phosphonates which are inhibitory to the two esterases. 
As described in the introductory paragraphs, we have demonstrated previ- 
ously that  the  activatable esterase of chemotaxis is characterized  by phos- 
phonate ester structure--activity profiles which are distinctive for each of the 
three series of phosphonates tested here, and are essentially the same whether 
determined by chemotactic factor-dependent inhibition (1)  or by protection 
against deactivation (5). Fig. 5 shows the inhibition profiles obtained when the 
phenylalkylphosphonates,  the  chloroalkylphosphonate,  and  the  alkylphos- 
phonates act on esterase 1 and on the activatable esterase of chemotaxis. Even 
though the inhibition profiles of esterase 1 differ distinctly from those given by 
esterase 2, they are strikingly similar to the profiles found when the same phos- 
phonates react with the  activatable esterase of chemotaxis as demonstrated 
both in chemotactic factor-dependent inhibition and protection against deac- 
tivation. 
DISCUSSION 
As has been indicated, it was the purpose of this work to obtain direct bio- 
chemical evidence for the hypothesis that the activatable  esterase of chemo- 
taxis is a  serine esterase of the leukocyte existing in a  precursor form which 
after activation becomes capable of hydrolyzing aromatic amino acid esters. In 
accord with the hypothesis, rabbit peritoneal polymorphonuclear leukocytes 
were found able to hydrolyze the aromatic amino acid ester, acetyl DL-phenyl- 
alanine ~-naphthol ester. The effects of pH, concentration of substrate, time 
and temperature of incubation,  and cell  concentration, all indicated the en- 
zymatic nature of this activity. 
As required  by the hypothesis, a  substantial part  of the  aromatic amino 
acid esterase activity is susceptible to inhibition by phosphonate esters (Table 
I). However, the phosphonate-susceptible activity was found due not to one 
esterase, but to two esterases, termed esterase 1 and esterase 2 (Figs. 2, 3, and 
4). The irreversible and progressive nature of the inactivation, as well as the ELMER  L.  BECKER  AND  PETER  A,  WARD  581 
particular linear form of the concentration dependence of the inhibition (Figs. 
2 and 3), indicates that both esterases are serine esterases. 
The enzymatic activity of esterase 1 is 10,000 or more times easily inhibited 
by the phosphonate than that of esterase 2 (Figs. 2 and 3). This very large dif- 
ference in ease of inactivation is not due to the existence in the leukocyte of a 
single esterase present in two different sites with widely varying accessibility 
to the inhibitors. This is most directly demonstrated by recent unpublished 
findings that the same differences in susceptibility to phosphonate  inhibitors 
exist in the esterase activity of homogenized or sonically disrupted cells. Further 
evidence that two enzymes are present is the very distinct difference in the 
inhibition profiles of esterase 1 and esterase 2 obtained with the three homol- 
ogons series of phosphonate esters (Fig. 4). 
Enzyme activity was found which was not inhibitable by the highest attain- 
able concentrations of phosphonate esters even  when the time of incubation 
was prolonged beyond the  15  rain used in the experiment of  Table I. This 
activity was attributed to a third esterase, esterase 3. We do not know whether 
esterase 3  is a  carboxylic acid esterase which cannot be  inactivated by or- 
ganophosphorus  inhibitors  (A  esterase  in  Aldridge's  classification  [8]) or 
whether it is merely that appropriate  organophosphorus inhibitors were not 
employed. It is not even certain that esterase 3 is a single esterase. No further 
work has been done with this enzyme. 
As already pointed out, esterase 1 differs sharply from esterase 2 in the inhibi- 
tion profiles it gives with  the various phenylalkylphosphonate, chloroalkyl- 
phospbonate, and alkylphosphonate esters. The inhibition profiles of the two 
esterases differ not only between themselves but from those given by chymo- 
trypsin, trypsin, acetylcholinesterase, Cqa (2, 3, 9), the esterases involved in 
the reactions of antigen-induced release of histamine from sensitized guinea 
pig lung (10),  or from rat peritoneal mast cells sensitized with homocytotropic 
antibody  (9),  or  the  complement-dependent  release  of histamine  from  rat 
peritoneal mast cells  sensitized with rabbit  anti-rat 7G-antibody (11).  This 
lack of similarity of the inhibition profiles of esterase 1 to either esterase 2 or 
any of the other cellular or noncellular esterases so far tested makes even more 
stril~ing the very great likeness of the inhibition profiles of esterase 1 to those 
of the activatable esterase of chemotaxis (Fig. 5). This gives added strength to 
the conclusion that esterase 1 is, in fact, the activated form of the activatable 
esterase. 
The range of concentrations required to inhibit the action of the activatable 
esterase in chemotaxis or in preventing deactivation is between 5  X  10  -4- 
1 )< 10  -4 ~  (1, 5). This is approximately 100,000 times greater than the concen- 
tration required to inhibit esterase 1 when it and the phosphonate are in con- 
tact for  15  min. The presumed explanation for this discrepancy is that the 
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phonate;  its  activity, whether in  chemotaxis or deactivation of chemotaxis, 
can be inhibited only in the interval between the activation of the esterase by 
contact of the cell with the chemotactic factor, C~(5,6,7)a,  and its action on 
the next component in the presumably lengthy sequence leading to chemotaxis. 
The 100,000-fold difference in concentrations referred to above suggests that 
this interval is of the order of I0 msec. 
The relationship of any of the three aromatic amino acid esterases to the 
esterases of the polymorphonuclear leukocyte described previously, for example 
the protease of the human granulocyte capable of hydrolyzing acetyltyrosine 
ethyl ester (12), is unknown. We have no suggestion to make at present for any 
specific functions for esterases 2 or 3. In view of the evidence just presented, 
that esterase 1 is an activated form of the proesterase involved in chemotaxis, 
we consider attractive the hypothesis that esterase 2, and possibly even esterase 
3, are activated forms of proesterases involved in other functions of the poly- 
morphonuclear leukocyte. 
Although we have obtained evidence that esterase 1 is the activated form of 
the activatable esterase of chemotaxis, we have not been able to show that it 
exists on the rabbit peritoneal polymorphonuclear leukocyte in an inert, pre- 
cursor form, nor have we had any but the most inconstant success in demon- 
strating  an  increase in  acetyl nL-phenylalanine B-naphthyl esterase  activity 
when the leukocyte is treated with chemotactic factor. The polymorphonuclear 
leukocytes used in our experiments migrated to the peritoneal cavity of the 
rabbit in response to the administration  of an in vivo chemotactic stimulus, 
glycogen. A possible reason for our failure to find precursor esterase 1 is that, 
in the course of responding to this stimulus, a very great portion of the activat- 
able esterase became activated. This possibility is strengthened by the finding 
that in in vitro tests only 5-40 % of the peritoneal cells can react to the chemo- 
tactic factor. For this reason, we have recently turned to a study of the blood 
polymorphonuclear leukocyte as a  source of acetyl DL-phenylalanine ~-naph- 
thyl esterase activity with the hope that more of the activatable esterase of 
this cell will  be in the precursor form. Preliminary results suggest  that  this 
hope may be realized. 
SUMMARY 
Previous  published  work  has  led  to  the  hypothesis  that  the  activatable 
esterase  of chemotaxis is  a  serine  esterase  of the  rabbit  polymorphonuclear 
leukocyte existing in an inert, phosphonate insusceptible form, which after ac- 
tivation is  capable of hydrolyzing aromatic amino  acid esters and  being in- 
hibited by phosphonates. In the present study, directed to the testing of this 
hypothesis, we have shown  that  rabbit peritoneal polymorphonuclear leuko- 
cytes contain three esterases capable of hydrolyzing the aromatic amino acid 
ester,  acetyl DL-phenylalanine ~3-naphthyl  ester. Two  of  these  esterases,  es- E.I.M~.R  L,  BECKER  AND  PETER  A,  WARD  583 
terase I  and esterase 2, are inhibited by various p-nitrophenyl ethyl phosphonate 
esters. The inhibition of each esterase is irreversible and progressive with time. 
When the logarithm of the esterase activity remaining after cell and inhibitor 
have been in contact for a constant time is plotted against the concentration of 
inhibitor, a straight line results. These results support the conclusion that both 
esterases  are serine esterases. The third esterase, esterase 3,  differs from the 
other two by its inability to be inactivated by any of the phosphonates no 
matter how high the concentration of phosphonate or prolonged the period of 
incubation of cell with phosphonate. 
The activity of esterase 1 is at least 10,000  times more easily inhibited by 
phosphonates than is that of esterase 2; incubating rabbit polyInorphonuclear 
leukocytes for 15 rain at 27°C with 10-9-10  -s ~  concentrations of various phos- 
phonates inactivates esterase 1, but it required 10-e-10  -4 ~  concentrations of 
the same phosphonates to inhibit esterase 2. The inhibition profiles of esterase 
1 are distinctly different from those of esterase 2 when the two esterases are 
tested  with  the  phenylalkylphosphonates,  chloroalkylphosphonates,  and 
alkylphosphonates. 
The inhibition profile of esterase  1  is  essentially the same  as  that  of the 
activatable esterase of chemotaxis obtained previously when the same three 
homologous series  of phosphonates  were  tested  for  their  ability  to  protect 
against deactivation by the chemotactic factor or give chemotactic-dependent 
inhibition. 
It is tentatively concluded that esterase 1 of the rabbit peritoneal neutrophil 
is the activated form of the activatable esterase of chemotaxis. 
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